DNM1L and breast carcinoma: In another study, inhibition of Drp1-dependent mitochondrial fission via siRNA against Drp1 or Mdivi-1 compromised the cytotoxic effect of cisplatin in MDA-MB-231 breast cancer cells via an inhibition of cisplatin-induced intracellular ROS production and recovery of mitochondrial membrane potential [92].